BD" Multi-Check CD4 Low Control 2.5 mL IVD - Product Usage: intended as a complete process contro...
FDA Device Recall #Z-0562-2021 — Class II — October 5, 2020
Recall Summary
| Recall Number | Z-0562-2021 |
| Classification | Class II — Moderate risk |
| Date Initiated | October 5, 2020 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Becton, Dickinson and Company, BD Biosciences |
| Location | San Jose, CA |
| Product Type | Devices |
| Quantity | 619 vials |
Product Description
BD" Multi-Check CD4 Low Control 2.5 mL IVD - Product Usage: intended as a complete process control for immunophenotyping by flow cytometry.
Reason for Recall
Recent product complaints showing an unexpected cell population exhibiting dim CD3 expression that may result in inaccurate results gating.
Distribution Pattern
Worldwide distribution - US Nationwide distribution including in the states of AL, CA, CO, CT, DE, FL, GA, IL, IN, KY, MA, MD, MI, NC, NJ, NV, NY, OH, OK, PA, PR, RI, SD, TN, TX, and VA. The countries of Canada, Belgium, Korea, India, Ecuador, Japan, Costa Rica, Australia, Vietnam, Pakistan, Singapore, Thailand, and Peru.
Lot / Code Information
Lot Number: BM1020L BD Multi-Check CD4 Low Control (US Distribution) Catalog Number UDI 349703 00382903497034 US 349704 00382903497041 US 349705 00382903497058 US BD" Multi-Check CD4 Low Control Whole Blood Control for Lymphocyte Subset Enumeration OUS Distribution Catalog Number UDI 340914 00382903409143 OUS only 340915 00382903409150 OUS only 340916 00382903409167 OUS only
Other Recalls from Becton, Dickinson and Company, BD Bio...
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-2351-2024 | Class II | BD Multitest 6-Color TBNK CE-IVD, REF: 644611; ... | May 8, 2024 |
| Z-0641-2024 | Class II | CD11b APC: ASR, REF: 340936, and CE, REF: 333143 | Oct 25, 2023 |
| Z-0173-2023 | Class II | BD Multitest 6-Color TBNK with optional BD Truc... | Oct 3, 2022 |
| Z-0171-2023 | Class II | BD Trucount Tubes (Cat. No. 340334), used for d... | Oct 3, 2022 |
| Z-0172-2023 | Class II | BD Trucount Tubes (Cat. No. 663028), used for d... | Oct 3, 2022 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.